168 related articles for article (PubMed ID: 1734286)
41. Crystal structure of yeast xylose reductase in complex with a novel NADP-DTT adduct provides insights into substrate recognition and catalysis.
Paidimuddala B; Mohapatra SB; Gummadi SN; Manoj N
FEBS J; 2018 Dec; 285(23):4445-4464. PubMed ID: 30269423
[TBL] [Abstract][Full Text] [Related]
42. Aldose reductase: monosaccharide autoxidation and NADPH binding.
Crabbe MJ
Biochem Soc Trans; 1996 Aug; 24(3):888-91. PubMed ID: 8878869
[No Abstract] [Full Text] [Related]
43. Sequence of pig lens aldose reductase and electrospray mass spectrometry of non-covalent and covalent complexes.
Jaquinod M; Potier N; Klarskov K; Reymann JM; Sorokine O; Kieffer S; Barth P; Andriantomanga V; Biellmann JF; Van Dorsselaer A
Eur J Biochem; 1993 Dec; 218(3):893-903. PubMed ID: 8281941
[TBL] [Abstract][Full Text] [Related]
44. Human aldose reductase: rate constants for a mechanism including interconversion of ternary complexes by recombinant wild-type enzyme.
Grimshaw CE; Bohren KM; Lai CJ; Gabbay KH
Biochemistry; 1995 Nov; 34(44):14356-65. PubMed ID: 7578039
[TBL] [Abstract][Full Text] [Related]
45. Substrate specificity of human aldose reductase: identification of 4-hydroxynonenal as an endogenous substrate.
Vander Jagt DL; Kolb NS; Vander Jagt TJ; Chino J; Martinez FJ; Hunsaker LA; Royer RE
Biochim Biophys Acta; 1995 Jun; 1249(2):117-26. PubMed ID: 7599164
[TBL] [Abstract][Full Text] [Related]
46. Studies on the inhibitor-binding site of porcine aldehyde reductase: crystal structure of the holoenzyme-inhibitor ternary complex.
el-Kabbani O; Carper DA; McGowan MH; Devedjiev Y; Rees-Milton KJ; Flynn TG
Proteins; 1997 Oct; 29(2):186-92. PubMed ID: 9329083
[TBL] [Abstract][Full Text] [Related]
47. Structure of conjugated polyketone reductase from Candida parapsilosis IFO 0708 reveals conformational changes for substrate recognition upon NADPH binding.
Qin HM; Yamamura A; Miyakawa T; Kataoka M; Nagai T; Kitamura N; Urano N; Maruoka S; Ohtsuka J; Nagata K; Shimizu S; Tanokura M
Appl Microbiol Biotechnol; 2014 Jan; 98(1):243-9. PubMed ID: 23828603
[TBL] [Abstract][Full Text] [Related]
48. Metabolism of the 2-oxoaldehyde methylglyoxal by aldose reductase and by glyoxalase-I: roles for glutathione in both enzymes and implications for diabetic complications.
Vander Jagt DL; Hassebrook RK; Hunsaker LA; Brown WM; Royer RE
Chem Biol Interact; 2001 Jan; 130-132(1-3):549-62. PubMed ID: 11306074
[TBL] [Abstract][Full Text] [Related]
49. Refined 1.8 A structure of human aldose reductase complexed with the potent inhibitor zopolrestat.
Wilson DK; Tarle I; Petrash JM; Quiocho FA
Proc Natl Acad Sci U S A; 1993 Nov; 90(21):9847-51. PubMed ID: 8234324
[TBL] [Abstract][Full Text] [Related]
50. Low apparent aldose reductase activity produced by monosaccharide autoxidation.
Wolff SP; Crabbe MJ
Biochem J; 1985 Mar; 226(3):625-30. PubMed ID: 2985042
[TBL] [Abstract][Full Text] [Related]
51. The role of Cys-298 in aldose reductase function.
Balendiran GK; Sawaya MR; Schwarz FP; Ponniah G; Cuckovich R; Verma M; Cascio D
J Biol Chem; 2011 Feb; 286(8):6336-44. PubMed ID: 21084309
[TBL] [Abstract][Full Text] [Related]
52. Structure of the His269Arg mutant of the rat aldose reductase-like protein AKR1B14 complexed with NADPH.
Sundaram K; Endo S; Matsunaga T; Tanaka N; Hara A; El-Kabbani O
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2012 Apr; 68(Pt 4):400-3. PubMed ID: 22505406
[TBL] [Abstract][Full Text] [Related]
53. Alkaloids as aldose reductase inhibitors, with special reference to berberine.
Gupta S; Singh N; Jaggi AS
J Altern Complement Med; 2014 Mar; 20(3):195-205. PubMed ID: 24236461
[TBL] [Abstract][Full Text] [Related]
54. X-ray structures of NADPH-dependent carbonyl reductase from Sporobolomyces salmonicolor provide insights into stereoselective reductions of carbonyl compounds.
Kamitori S; Iguchi A; Ohtaki A; Yamada M; Kita K
J Mol Biol; 2005 Sep; 352(3):551-8. PubMed ID: 16095619
[TBL] [Abstract][Full Text] [Related]
55. Studies on pig muscle aldose reductase. Kinetic mechanism and evidence for a slow conformational change upon coenzyme binding.
Kubiseski TJ; Hyndman DJ; Morjana NA; Flynn TG
J Biol Chem; 1992 Apr; 267(10):6510-7. PubMed ID: 1551865
[TBL] [Abstract][Full Text] [Related]
56. Human aldose reductase: subtle effects revealed by rapid kinetic studies of the C298A mutant enzyme.
Grimshaw CE; Bohren KM; Lai CJ; Gabbay KH
Biochemistry; 1995 Nov; 34(44):14366-73. PubMed ID: 7578040
[TBL] [Abstract][Full Text] [Related]
57. Human aldose reductase: pK of tyrosine 48 reveals the preferred ionization state for catalysis and inhibition.
Grimshaw CE; Bohren KM; Lai CJ; Gabbay KH
Biochemistry; 1995 Nov; 34(44):14374-84. PubMed ID: 7578041
[TBL] [Abstract][Full Text] [Related]
58. Understanding the binding of daunorubicin and doxorubicin to NADPH-dependent cytosolic reductases by computational methods.
Pirolli D; Giardina B; Mordente A; Ficarra S; De Rosa MC
Eur J Med Chem; 2012 Oct; 56():145-54. PubMed ID: 22982121
[TBL] [Abstract][Full Text] [Related]
59. Unusual binding mode of the 2S4R stereoisomer of the potent aldose reductase cyclic imide inhibitor fidarestat (2S4S) in the 15 K crystal structure of the ternary complex refined at 0.78 A resolution: implications for the inhibition mechanism.
Zhao HT; Hazemann I; Mitschler A; Carbone V; Joachimiak A; Ginell S; Podjarny A; El-Kabbani O
J Med Chem; 2008 Mar; 51(5):1478-81. PubMed ID: 18284183
[TBL] [Abstract][Full Text] [Related]
60. Comparison of hydrogen determination with X-ray and neutron crystallography in a human aldose reductase-inhibitor complex.
Blakeley MP; Mitschler A; Hazemann I; Meilleur F; Myles DA; Podjarny A
Eur Biophys J; 2006 Sep; 35(7):577-83. PubMed ID: 16622654
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
